ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1787

Spatial and Quantitative Semiautomated Image Analysis of Synovial Biopsies Studied Using a Novel High-Plex Immunofluorescence Platform

Estefania Quesada-Masachs1, Luis Peñaranda Bolaño1, Aakriti Arora2, Jessica Murillo-Saich3, Edward Lo4, Tad George4, Daniel Tanoeihusada4, Sara McArdle5 and Monica Guma6, 1University of Miami, Miami, FL, 2University of Miami / Jackson Memorial Hospital, Miami, FL, 3University of California, San Diego, San Diego, CA, 4RareCyte, Seattle, WA, 5La Jolla Institute for Immunology, La Jolla, CA, 6University of California San Diego, San Diego, CA

Meeting: ACR Convergence 2025

Keywords: Fibroblasts, Synovial, immunology, macrophages, Miscellaneous Rheumatic and Inflammatory Diseases, Tissue Engineering

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1780–1808) Osteoarthritis & Joint Biology – Basic Science Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Although not part of the formal ACR criteria for RA, PsA, or OA, synovial pathology can be a helpful tool in clinical practice. Histopathologic evaluation in RA has led to the development of a synovitis score and a joint pathology algorithm. Three synovial pathotypes—lympho-myeloid, diffuse-myeloid, and pauci-immune—have been described, but are based on a limited number of markers and currently provide limited clinical information. Recent advances allow for minimally invasive synovial biopsies and multiplex microscopy to provide mechanistic insights into tissue pathology. This is especially relevant as targeted therapies for OA are still lacking. Artificial intelligence (AI) enables detailed image analysis, preserving spatial context, allowing for single-cell quantification and identification of cellular interactions that may inform therapy and predict response. Our objective was to apply a novel high-plex IF platform coupled with a semi-automated image analysis approach using machine learning algorithms to characterize synovial inflammatory infiltrates in patients with PsA, RA, and OA

Methods: FFPE synovial tissue biopsies from nine patients from patients with RA (n=5), OA (n=2), and PsA (n=2) were stained with a 17-marker IF panel targeting nuclei, CD31, CD68, CD163, CD20, CD4, CD8a, CD45RO, PD-L1, CD3e, Ki-67, PD-1, FOXP3, CD45, Pan-CK, vimentin, and SMA. Some RA and PsA samples had prior classification (lymphoid or lympho-myeloid) based on conventional IF/IHC staining. Whole sections were scanned at 20x using the Orion platform.A semi-automated AI pipeline originally developed for pancreatic tissue was adapted to synovial tissue. Regions of interest (ROIs, lining and sublining) were selected. Cell classification was based on fluorescence intensity and morphology. Spatial context and cellular neighborhoods were also analyzed using unsupervised clustering algorithms

Results: Nine synovial biopsies from five male and five female (mean age 59.1 years, SD10.1) with a total of 105,364 cells across 130 ROIs were analyzed over 23.7 mm² of tissue. Cellular density was higher in the lining (mean 10,461 cells/mm²) than in the sublining (mean 5,017 cells/mm²). As expected, OA showed fewer immune cells, fibroblasts, and vessels than RA and PsA. Macrophage and fibroblast predominance was observed across all samples, especially in immune-mediated arthritis. In RA, T cell infiltration was more abundant in the sublining, and proportions of T cell subsets were similar across knees and wrists. Distinct cellular clusters were identified in the unsupervised analysis, differentiating between diseases

Conclusion: These preliminary findings support the suitability of this new high-plex microscopy technology and AI-driven image analysis in assessing synovial inflammation. Despite limited tissue, we achieved robust, high-resolution profiling of thousands of cells. We envision that this type of data may help create algorithms in joint pathology to further aid in patient management. Novel platforms currently restricted to research can be incorporated into the clinical arena to serve as a diagnostic tool as well as a personalized treatment tool based on a patient’s specific histological characteristics

Supporting image 1


Disclosures: E. Quesada-Masachs: None; L. Peñaranda Bolaño: None; A. Arora: None; J. Murillo-Saich: None; E. Lo: Rarecyte, 3; T. George: RareCyte, 3; D. Tanoeihusada: RareCyte, 3; S. McArdle: None; M. Guma: AbbVie, 5, Sonoma, 5.

To cite this abstract in AMA style:

Quesada-Masachs E, Peñaranda Bolaño L, Arora A, Murillo-Saich J, Lo E, George T, Tanoeihusada D, McArdle S, Guma M. Spatial and Quantitative Semiautomated Image Analysis of Synovial Biopsies Studied Using a Novel High-Plex Immunofluorescence Platform [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/spatial-and-quantitative-semiautomated-image-analysis-of-synovial-biopsies-studied-using-a-novel-high-plex-immunofluorescence-platform/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/spatial-and-quantitative-semiautomated-image-analysis-of-synovial-biopsies-studied-using-a-novel-high-plex-immunofluorescence-platform/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology